Tapping Test for Parkinson's (NCT06378619)
Distinguish Parkinson from essential tremor
- Trial ID
- NCT06378619
- Official Title
- Machine Learning Analysis Of The Tapping Test And The Archimedean Spiral For The Differential Diagnosis Of Essential Tremor And Parkinson's Disease.
- Goal
- Distinguish Parkinson from essential tremor
- Status
- RECRUITING
- Sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf
- Study Type
- OBSERVATIONAL
- Enrollment
- 110 participants
- Conditions
- Tremor, Essential Tremor, Parkinson Disease
- Interventions
- Tapping Test, Archimedes Spiral
Summary For Families
The goal is to build a tool that helps tell whether a person’s tremor comes from Parkinson’s disease or from essential tremor, because those diagnoses lead to different care needs. To do that, 110 people with a confirmed diagnosis will do two simple tests, a finger tapping test and drawing an Archimedean spiral, while researchers use machine learning to look for movement patterns that differ between the two conditions. The study is looking for people aged 45 to 79 who already have a clear diagnosis of tremor due to Parkinson’s disease with slowed movement and early-stage disease, or a clear diagnosis of essential tremor with at least three years of stable follow-up and no slowed movement. People on antipsychotics, antidepressants, dopamine-stimulating medicines, or primidone, those with marked involuntary movements, tremor so severe it prevents tracing, major cognitive or mood problems, or certain other conditions like heavy alcohol use, peripheral nerve disease, dystonia, or prior stroke are not eligible.
Locations
- Hospital Sant Camil-Consorci Sanitari Alt'Pènedes i Garraf, Barcelona, Catalonia, Spain
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Tapping Test. The goal is to build a tool that helps tell whether a person’s tremor comes from Parkinson’s disease or from essential tremor, because those diagnoses lead to different care needs. To do that, 110 people with a confirmed diagnosis will do two simple tests, a finger tapping test and drawing an Archimedean spiral, while researchers use machine learning to look for movement patterns that differ between the two conditions. The study is looking for people aged 45 to 79 who already have a clear diagnosis of tremor due to Parkinson’s disease with slowed movement and early-stage disease, or a clear diagnosis of essential tremor with at least three years of stable follow-up and no slowed movement. People on antipsychotics, antidepressants, dopamine-stimulating medicines, or primidone, those with marked involuntary movements, tremor so severe it prevents tracing, major cognitive or mood problems, or certain other conditions like heavy alcohol use, peripheral nerve disease, dystonia, or prior stroke are not eligible.
- Who can participate?
- Participants must be between 45 Years and 79 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 2 years.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.